Mifepristone & Misoprostol for Midtrimester Termination of Pregnancy in

See also
Status	Clinical Trial	Phase
Completed	`NCT03710239` - OPIOID Study - Pain With Osmotic Dilators	N/A
Completed	`NCT05046041` - Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal	Phase 4
Completed	`NCT01766388` - Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia	N/A
Completed	`NCT03346629` - Outpatient Service for Mid-trimester Termination of Pregnancy	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT03710239 - OPIOID Study - Pain With Osmotic Dilators

N/A

Completed

NCT05046041 - Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal

Phase 4

Completed

NCT01766388 - Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia

N/A

Completed

NCT03346629 - Outpatient Service for Mid-trimester Termination of Pregnancy

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02235155
Study type	Observational
Source	Gynuity Health Projects
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	November 2015

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms